Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Nicotine: does it have a role in the treatment of skin disease?

Ingram, John R. 2009. Nicotine: does it have a role in the treatment of skin disease? Postgraduate Medical Journal 85 (1002) , pp. 196-201. 10.1136/pgmj.2008.073577.

Full text not available from this repository.


Epidemiological evidence suggests that, although smoking is detrimental in some skin diseases, it is of benefit in others such as pemphigus and Behcet disease. Evidence that nicotine is of therapeutic value in selected skin diseases is limited to case reports. There has been renewed interest in nicotinic acetylcholine receptor agonists, such as nicotine, after the discovery of a "nicotinic anti-inflammatory pathway". Nicotinic acetylcholine receptors exist in abundance in human skin, but it is unknown whether they exert an anti-inflammatory effect. Randomised controlled trials of nicotine preparations in those skin conditions that occur less often in smokers are necessary to establish the value of nicotine, if any, in the treatment of skin disease.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > RL Dermatology
Publisher: BMJ Publishing Group
ISSN: 0032-5473
Last Modified: 04 Jun 2017 08:47

Citation Data

Actions (repository staff only)

Edit Item Edit Item